Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Jan 6, 2005


Stratagene and Harvard Bio Only Gainers as BCW Index Falls

Shares of Stratagene jumped 10 percent and shares of Harvard Bioscience improved a fraction as the BioCommerce Week Index returned after the holiday break.

Stratagene closed at the end of trading Tuesday at $7.37, up over the previous closing price of $6.70 on Dec. 21 before the holiday break, while Harvard Bio improved to $4.37 from the previous close of $4.35.

Bruker BioSciences dropped 11 percent during the period, closing Tuesday at $3.80, down from $4.29, as a total of 13 companies in the index saw share prices fall.

Thermo Electron, which filed a patent-infringement lawsuit against Applera in December, followed Bruker, losing 4 percent, closing at $29.31, down from $30.58 (see story, page 1).

Overall, the index fell 2 percent as the overall market indices all dropped on Tuesday reacting to news that the Federal Reserve expressed concern in its December meeting that interest rates were too low to contain inflation. The Nasdaq index closed with its largest one-day percentage decline in five months. Since the last day of trading in 2004, the Dow Jones index has fallen 1.4 percent while the S&P 500 declined nearly 2 percent in the same period. The Amex biotechnology index dropped nearly 4 percent in that same period while the Amex pharmaceutical index fell 2 percent.

Following is a preliminary schedule of quarterly financial reporting dates for the BCW Index companies:

  • Agilent: No date set
  • Applied Biosystems: No date set
  • Becton Dickinson: Jan. 24
  • Beckman Coulter: Jan. 28
  • Bio-Rad: Feb. 17
  • Bruker BioScience: No date set
  • General Electric: Jan. 21
  • Harvard Bioscience: No date set
  • Invitrogen: No date set
  • Molecular Devices: Jan. 31
  • Sigma-Aldrich: Feb. 8
  • Stratagene: Feb. 7
  • Thermo: Feb. 2
  • Waters: No date set
File Attachments
The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.